EXTEND (Eltrombopag eXTENded Dosing Study): An extension study of eltrombopag olamine (SB-497115-GR) in adults, with idiopathic thrombocytopenic purpura (ITP), previously enrolled in an eltrombopag study

Registry ID

EUCTR2006-000471-14

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

GlaxoSmithKline Research and Development Limited

Start date

2006-05-25

Last update

2026-08-16

Conditions

• Immune thrombocytopenic purpura (ITP)
• chronic immune (idiopathic) thrombocytopenic purpura (ITP)
• Idiopathic thrombocytopenic purpura

Summary

To describe the long-term safety and tolerability of oral eltrombopag treatment of subjects with ITP with or without concomitant ITP medication.

Locations

• , , Ireland
• , , Finland
• , , Austria
• , , Germany
• , , Greece
• , , Slovenia
• , , Spain
• , , Czechia
• , , France
• , , UK
• , , Netherlands
• , , Denmark
• , , Sweden
• , , Italy
• , , Slovakia

Related clinical trials

• Platelet activation and procoagulant platelets in patients with immune thrombocytopenia: a prospective study

View on source registry